Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.19.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock
Additional Paid in Capital
Accumulated (Deficit)
Total
Beginning Balance, Shares at Dec. 31, 2016 73,509,663      
Beginning Balance, Amount at Dec. 31, 2016 $ 73,510 $ 40,031,625 $ (43,763,379) $ (3,658,244)
Stock issued upon debt conversion, Shares 51,236      
Stock issued upon debt conversion, Amount $ 51 25,567 25,618
Stock issued upon cashless warrant exercise, Shares 630,214      
Stock issued upon cashless warrant exercise, Amount $ 630 (630)
Stock issued for the acquisition of patents rights, Shares 925,000      
Stock issued for the acquisition of patents rights, Amount $ 925 517,075 518,000
Stock issued to non-employees, Shares 1,000,000      
Stock issued to non-employees, Amount $ 1,000 230,250 231,250
Stock issued per settlement agreement, Shares 130,000      
Stock issued per settlement agreement, Amount $ 130 60,970 61,100
Re-issuance of warrants 17,922 17,922
Issuance of stock options 1,282,841 1,282,841
Net loss (2,903,273) (2,903,273)
Ending Balance, Shares at Dec. 31, 2017 76,246,113      
Ending Balance, Amount at Dec. 31, 2017 $ 76,246 42,165,620 (46,666,652) (4,424,786)
Issuance of stock options 351,770 351,770
Vesting of stock issued to non-employees in prior year 138,750 138,750
Issuance of warrants 129,850 129,850
Net loss (4,816,680) (4,816,680)
Ending Balance, Shares at Dec. 31, 2018 76,246,113      
Ending Balance, Amount at Dec. 31, 2018 $ 76,246 $ 42,785,990 $ (51,483,332) $ (8,621,096)